| 01/08/14 | 12:30:02 | 1 Aug 2014 | | Director/PDMR Shareholding | RNS |
| 31/07/14 | 08:00:28 | 31 Jul 2014 | | AstraZeneca Pipeline | RNS |
| 31/07/14 | 08:00:25 | 31 Jul 2014 | | Second Quarter & Half Year Results 2014 | RNS |
| 30/07/14 | 10:00:01 | 30 Jul 2014 | | Notice of Results | RNS |
| 30/07/14 | 08:00:34 | 30 Jul 2014 | | STRATEGIC RESPIRATORY TRANSACTION WITH ALMIRALL | RNS |
| 01/07/14 | 16:30:04 | 1 Jul 2014 | | Total Voting Rights | RNS |
| 01/07/14 | 13:00:05 | 1 Jul 2014 | | Director/PDMR Shareholding | RNS |
| 26/06/14 | 15:00:02 | 26 Jun 2014 | | Director/PDMR Shareholding | RNS |
| 26/06/14 | 08:00:09 | 26 Jun 2014 | | FDA Advisory Committee votes on olaparib | RNS |
| 24/06/14 | 18:30:02 | 24 Jun 2014 | | Publication of Prospectus | RNS |
| 18/06/14 | 12:00:02 | 18 Jun 2014 | | Holding(s) in Company | RNS |
| 18/06/14 | 11:00:08 | 18 Jun 2014 | | Director/PDMR Shareholding | RNS |
| 18/06/14 | 11:00:08 | 18 Jun 2014 | | Director/PDMR Shareholding | RNS |
| 13/06/14 | 16:00:02 | 13 Jun 2014 | | Clarification of AXA shareholding in AstraZeneca | RNS |
| 13/06/14 | 08:00:09 | 13 Jun 2014 | | FDA AdCom recommends no CV trial for PAMORA class | RNS |
| 12/06/14 | 08:00:05 | 12 Jun 2014 | | ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001 | RNS |
| 11/06/14 | 08:00:09 | 11 Jun 2014 | | AZ TO PRESENT NEW DATA AT ADA | RNS |
| 03/06/14 | 15:30:01 | 3 Jun 2014 | | ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO | RNS |
| 03/06/14 | 08:00:36 | 3 Jun 2014 | | ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO | RNS |
| 02/06/14 | 15:00:03 | 2 Jun 2014 | | Blocklisting Interim Review | RNS |
| 02/06/14 | 14:30:01 | 2 Jun 2014 | | Total Voting Rights | RNS |
| 27/05/14 | 08:00:26 | 27 May 2014 | | STATEMENT REGARDING PFIZER WITHDRAWAL | RNS |
| 23/05/14 | 12:00:03 | 23 May 2014 | | Rule 2.10 Announcement | RNS |
| 22/05/14 | 12:00:03 | 22 May 2014 | | Rule 2.10 Announcement | RNS |
| 21/05/14 | 12:29:11 | 21 May 2014 | | Rule 2.10 Announcement | RNS |
| 20/05/14 | 19:17:52 | 20 May 2014 | | CLARIFICATION REGARDING PFIZER STATEMENT | RNS |
| 20/05/14 | 12:00:03 | 20 May 2014 | | Rule 2.10 Announcement | RNS |
| 19/05/14 | 12:00:05 | 19 May 2014 | | Rule 2.10 Announcement | RNS |
| 19/05/14 | 08:08:57 | 19 May 2014 | | ASTRAZENECA BOARD REJECTS PFIZER'S FINAL PROPOSAL | RNS |
| 16/05/14 | 12:00:09 | 16 May 2014 | | Rule 2.10 Announcement | RNS |
| 15/05/14 | 14:52:58 | 15 May 2014 | | CONTINUING PROGRESS IN LATE STAGE PIPELINE | RNS |
| 15/05/14 | 12:00:10 | 15 May 2014 | | Rule 2.10 Announcement | RNS |
| 15/05/14 | 08:00:18 | 15 May 2014 | | AstraZeneca oncology pipeline update ahead of ASCO | RNS |
| 14/05/14 | 12:00:02 | 14 May 2014 | | Rule 2.10 Announcement | RNS |
| 14/05/14 | 08:00:14 | 14 May 2014 | | MedImmune announces immuno-oncology collaboration | RNS |
| 13/05/14 | 12:15:58 | 13 May 2014 | | STATEMENT REGARDING PFIZER ANNOUNCEMENT | RNS |
| 13/05/14 | 12:00:12 | 13 May 2014 | | Rule 2.10 Announcement | RNS |
| 13/05/14 | 08:00:40 | 13 May 2014 | | AZ PHASE III SAXA/DAPA RESULTS | RNS |
| 12/05/14 | 17:01:02 | 12 May 2014 | | AZ ANNOUNCES RESULTS OF PHASE IIB STUDIES | RNS |
| 12/05/14 | 17:00:02 | 12 May 2014 | | AZ TO PRESENT DATA AT ATS 2014 | RNS |
| 12/05/14 | 12:00:02 | 12 May 2014 | | Rule 2.10 Announcement | RNS |
| 12/05/14 | 08:00:18 | 12 May 2014 | | AMGEN & AZ BRODALUMAB PHASE III RESULTS | RNS |
| 09/05/14 | 12:00:02 | 9 May 2014 | | Rule 2.10 Announcement | RNS |
| 08/05/14 | 13:31:14 | 8 May 2014 | | ASTRAZENECA INITIATES PHASE III STUDY FOR MEDI4736 | RNS |
| 08/05/14 | 12:02:44 | 8 May 2014 | | Rule 2.10 Announcement | RNS |
| 07/05/14 | 18:30:03 | 7 May 2014 | | Holding(s) in Company | RNS |
| 07/05/14 | 12:00:02 | 7 May 2014 | | Rule 2.10 Announcement | RNS |
| 06/05/14 | 16:30:01 | 6 May 2014 | | Changes to membership of Board Committees | RNS |
| 06/05/14 | 12:30:01 | 6 May 2014 | | Rule 2.10 Announcement | RNS |
| 06/05/14 | 12:00:02 | 6 May 2014 | | ASTRAZENECA ISSUES UPDATE ON STRATEGY | RNS |
